The Trial Lawyer, A Magazine for Trial Lawyers & a Voice for Justice, re-reported an important article in the N.Y. Times about how non-FDA-approved hip implants were shipped off-shore instead. Here's an excerpt demonstrating the typical shift-the-blame stance taken by manufacturing conglomerates regarding the risks of their defective products:
Before the recall, DePuy long defended the articular surface replacement device, saying that any failures associated with it reflected failures by surgeons to properly implant the hip cup. The surgeons who performed the study of the resurfacing version of the device that was rejected by the F.D.A. were handpicked by DePuy and included the model’s designers.
Dr. Antoni Nargol, an orthopedic surgeon in England who worked on the study that DePuy submitted to the F.D.A. and later became a critic of the device, said in a telephone interview that the company had never informed him that its application for approval in the United States had been rejected.
Thousands of people now face pain and injury due to defective hip implants. Contact the firm if you have questions about the safety of your hip implant and your legal rights.